Product Details: Acomplia (Rimonabant)

Brand Name Options - Manufacturer: Sanofi-Aventis

Generic Options

What are Generics? A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, how it is taken, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name and works the same way in the body in the same amount of time.

The only differences between generics and their brand-name counterparts is the generics are less expensive and may look slightly different (e.g. different shape or color), as trademark laws prevent a generic from looking exactly like the brand-name drug.

Generics are less expensive because generic manufacturers don't have to invest large sums of money to invent a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name drug and sell it at substantial discounts.

Description

Acomplia is a Cannabinoid-1 Receptor Blockers (CB1) used in the treatment of obesity and related conditions. Acomplia 20mg tablets are indicated as an adjunct to diet and exercise for the treatment of obese patients (BMI 30 kg/m2), or overweight patients (BMI > 27 kg/m2) with associated risk factor(s), such as type 2 diabetes or dyslipidaemia.

Directions

In adults, the recommended dosage is one Acomplia 20 mg tablet daily to be taken in the morning before breakfast. The treatment should be introduced with a mildly reduced calorie diet. The safety and efficacy of Acomplia have not been evaluated beyond 2 years. In the elderly, no dosage adjustment is required. Acomplia should be used with caution in patients over 75 years of age . No dosage adjustment is required for patients with mild or moderate hepatic impairment. Acomplia should be used with caution in patients with moderate hepatic impairment. Acomplia should not be used in patients with severe hepatic impairment. No dosage adjustment is required for patients with mild and moderate renal impairment. Acomplia should not be used in patients with severe renal impairment. Acomplia is not recommended for use in children below age 18 due to a lack of data on efficacy and safety.

Cautions

Tell your doctor before you start to take this medicine: if you have impaired liver function, if you have severely impaired renal function, if you are currently being treated for epilepsy, if you are less than 18 years of age. There is no information available on the use of Acomplia in people under 18 years of age.

Side Effects

Common side effects, that affect more than 1 per 10, that have occurred in patients on Acomplia include: nausea and upper respiratory tract infection. Common side effects, that affect more than 1 per 100 but less than 1 per 10, that have occurred in patients on Acomplia include: upset stomach, vomiting, trouble with sleeping, nervousness, depression, irritability, dizziness, diarrhoea, anxiety, itching, excessive sweating, muscle cramps or spasm, fatigue, bruising, tendon pain and inflammation (tendonitis), memory loss, back pain (sciatica), altered sensitivity of the hands and feet, hot flushes, falls, influenza, and joint sprain. Uncommon side effects, that affects less than 1 per 100 but more than 1 per 1000, that have occurred in patients on Acomplia include: sleepiness (lethargy), night sweats, panic symptoms, hiccups, anger, restlessness (dysphoria), emotional disorder. Rare side effects, that affect less than 1 per 1000, that have occurred in patients on Acomplia include: hallucinations. If any of the side effects gets serious, or if you notice any side effects not listed here, please tell your doctor or pharmacist.

Active Ingredients

Rimonabant